TOBAM’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

TOBAM’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-463	Closed	-$95K	–	433
2022 Q4	$95K	Buy	463 +349	+306%	+$88.2K	0.01%	308
2022 Q3	$32K	Buy	+114	New	+$29K	﹤0.01%	398

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TOBAM's SWAV Position: Q1 2023 in Review

TOBAM sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 463 shares — an estimated $95K sold.

TOBAM first reported a position in SWAV in Q3 2022 and held it in 2 quarters. The position peaked at $95K in Q4 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

TOBAM reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
TOBAM sold 463 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $95K.
TOBAM first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
TOBAM's Shockwave Medical, Inc. Common Stock position peaked at $95K in Q4 2022.
381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.